|
14.1.2006 |
EN |
Official Journal of the European Union |
C 10/16 |
Action brought on 23 November 2005 by the Commission of the European Communities against the French Republic
(Case C-414/05)
(2006/C 10/32)
Language of the case: French
An action against the French Republic was brought before the Court of Justice of the European Communities on 23 November 2005 by the Commission of the European Communities, represented by B. Stromsky, acting as Agent, with an address for service in Luxembourg.
The Commission claims that the Court should:
|
1. |
declare that, by failing to take the legislative, regulatory and administrative provisions necessary to comply with Commission Directive 2003/94/EC of 8 October 2003 laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use (1), the French Republic has failed to fulfil its obligations under that directive, and |
|
2. |
declare that, in any event, by failing to communicate to the Commission the legislative, regulatory and administrative provisions necessary to comply with Commission Directive 2003/94/EC of 8 October 2003 laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use, the French Republic has failed to fulfil its obligations under that directive, |
|
3. |
order the French Republic to pay the costs. |
Pleas in law and main arguments
The Commission points out that the period for transposing that directive expired on 30 April 2004.
(1) OJ L 262, 14.10.2003, p. 22